- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07675798
Effect of Caudal Block on Urethrocutaneous Fistula After Distal Hypospadias Repair
The Effect of Caudal Block on the İncidence of Urethrocutaneous Fistula After Distal Hypospadias Repair: A Multicentre, Randomized Controlled Trial
Hypospadias is one of the most common congenital urogenital anomalies in males, occurring in approximately 1 in every 200-300 male births. It is characterized by abnormal positioning of the urethral meatus on the ventral surface of the penis. Surgical repair is the standard treatment; however, urethrocutaneous fistula formation remains one of the most frequent and clinically significant postoperative complications, potentially requiring reoperation and causing considerable distress to both the patient and the family.
Caudal nerve block is a widely used regional anesthesia technique in pediatric lower abdominal and genitourinary surgery, valued for its high analgesic efficacy, relative ease of application, and low complication profile. However, emerging evidence suggests that caudal block may be associated with an increased incidence of postoperative complications following hypospadias repair, including fistula formation and wound edema. Notably, Kundra et al. (2012) reported a fistula rate of 19.2% in patients who received caudal block, compared to 0% in those who received penile block, raising important questions about the routine use of caudal block in hypospadias surgery.
This prospective, multicenter, randomized controlled trial aims to evaluate the effect of caudal block on the incidence of urethrocutaneous fistula following distal hypospadias repair. A total of 80 male patients aged 6-60 months will be randomized 1:1 to either receive general anesthesia with caudal block or general anesthesia alone. The primary outcome is the incidence of urethrocutaneous fistula. Secondary outcomes include perioperative opioid consumption, postoperative pain scores, analgesic duration, and other surgical complications such as wound dehiscence and urethral stricture. Patients will be followed up for 3-6 months postoperatively. The study will be conducted across four centers in Turkey. Results are expected to provide evidence-based guidance on the role of caudal block in pediatric hypospadias repair.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Fikret Salık, associate professor
- Telefonnummer: +905076214125
- E-post: fikretsalik@gmail.com
Studera Kontakt Backup
- Namn: Fikret Salık
- Telefonnummer: 05076214125
- E-post: fikretsalik@gmail.com
Studieorter
-
-
Eyalet/Yerleşke
-
Diyarbakır, Eyalet/Yerleşke, Turkiet (Türkiye), 21070
- Rekrytering
- Dicle University
-
Kontakt:
- Fikret Salık
- Telefonnummer: 05076214125
- E-post: fikretsalik@gmail.com
-
Diyarbakır, Eyalet/Yerleşke, Turkiet (Türkiye), 21070
- Rekrytering
- Gazi Yasargil Training and Research Hospital
-
Kontakt:
- Mustafa Bıçak
- Telefonnummer: 05320571437
- E-post: drmustafabicak@gmail.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Barn
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Male patients aged 6-60 months
- Diagnosed with distal hypospadias
- Scheduled for elective hypospadias repair
- Written informed consent obtained from parent or legal guardian
Exclusion Criteria:
- Age < 6 months or > 60 months
- Proximal or non-distal hypospadias
- Previous hypospadias repair
- Skin lesions at the epidural/caudal injection site
- Coagulopathy
- Known allergy to anesthetic agents, particularly bupivacaine hydrochloride
- Spinal anomalies
- Chronic granulomatous disease
- Diabetes mellitus
- Patients receiving corticosteroid therapy
- Refusal of informed consent by parent or guardian
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Group 1) Caudal Block Group
General anesthesia combined with caudal block administered prior to distal hypospadias repair.
Caudal block is performed using bupivacaine hydrochloride as part of standard institutional analgesic protocol.
|
General anesthesia combined with caudal block administered prior to distal hypospadias repair.
Caudal block is performed using bupivacaine hydrochloride as part of standard institutional analgesic protocol.
|
|
Aktiv komparator: Group 2) Non-Caudal Group
General anesthesia alone administered without caudal block for distal hypospadias repair.
Intravenous analgesic agents used as per standard institutional protocol.
|
General anesthesia alone administered without caudal block for distal hypospadias repair.
Intravenous analgesic agents used as per standard institutional protocol.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of Urethrocutaneous Fistula
Tidsram: up to 3 months
|
Development of urethrocutaneous fistula following distal hypospadias repair, assessed by clinical examination
|
up to 3 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Postoperative Pain Scores
Tidsram: Up to 24 hours postoperatively
|
Postoperative pain assessed using age-appropriate pain scales (e.g., Visual Analog Scale or FLACC scale, where higher scores indicate worse pain).
|
Up to 24 hours postoperatively
|
|
Surgical Complications
Tidsram: Up to 3 months
|
Incidence of surgery-related complications
|
Up to 3 months
|
|
Duration of Effective Analgesia
Tidsram: Up to 24 hours postoperatively
|
The time from the completion of the surgical/anesthetic procedure until the patient first requests or requires rescue analgesia.
|
Up to 24 hours postoperatively
|
|
Total Consumption of Rescue Analgesics
Tidsram: Up to 24 hours postoperatively
|
The total amount (mg) of rescue analgesic medications required by the patient during the postoperative period.
|
Up to 24 hours postoperatively
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Genitala sjukdomar
- Genitala sjukdomar, manliga
- Manliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar och graviditetskomplikationer
- Medfödda abnormiteter
- Urogenitala abnormiteter
- Penissjukdomar
- Medfödda, ärftliga och neonatala sjukdomar och abnormiteter
- Hypospadi
- Anestesi och analgesi
- Anestesi
- Anestesi, allmän
Andra studie-ID-nummer
- 357/2025
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .